Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the Role of MTMR5 in a Novel Zebrafish Model of CMT4B3
EF 2023-24
Résumé
Charcot-Marie-Tooth disease type 4B3 (CMT4B3) is a rare childhood disease that affects an individual’s muscular and nervous systems. CMT4B3 patients have alterations in their skeletal muscle, structural brain changes, and progressive lower limb weakness that ultimately leads to wheelchair dependence. The disease is caused by variants in the human MTMR5 gene. There are currently no treatments for CMT4B3, and little is currently known about the MTMR5 protein. To gain a better understanding of the protein and its role in disease pathology, my lab generated a zebrafish model of CMT4B3 using CRISPR/Cas9 technology. The zebrafish and human MTMR5 proteins are highly conserved, and deletion of the mtmr5 gene in zebrafish results in a phenotype similar to that of human CMT4B3 patients. The goal of my research project is to utilize the CMT4B3 zebrafish model to investigate the role of MTMR5 in nerve development and identify disease-related phenotypes that are suitable for large-scale drug screens. I hypothesize that the CMT4B3 zebrafish will facilitate the efficient discovery of novel therapies that can be translated to patients with CMT4B3. To investigate the role of MTMR5, I plan to study the central and peripheral nervous system of CMT4B3 zebrafish using various experimental techniques, such as electron microscopy and RNA sequencing. I also plan on tagging the zebrafish MTMR5 protein with a fluorescent label to investigate its tissue-specific patterning, sub-cellular localization, and protein-protein interactions in both healthy and affected neural development. Successful completion of this research project will lead to the identification of the first potential therapeutics for CMT4B3.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506446
Name
Lindzon Jordan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Role of MTMR5 in a Novel Zebrafish Model of CMT4B3
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Charcot-Marie-Tooth Disease; Disease Models; Drug Discovery; Live Imaging; Mtmr5/Sbf1; Neuromuscular Disorders; Rare Disease; Translational Research; Zebrafish
Abstract
Charcot-Marie-Tooth disease type 4B3 (CMT4B3) is a rare childhood disease that affects an individual’s muscular and nervous systems. CMT4B3 patients have alterations in their skeletal muscle, structural brain changes, and progressive lower limb weakness that ultimately leads to wheelchair dependence. The disease is caused by variants in the human MTMR5 gene. There are currently no treatments for CMT4B3, and little is currently known about the MTMR5 protein. To gain a better understanding of the protein and its role in disease pathology, my lab generated a zebrafish model of CMT4B3 using CRISPR/Cas9 technology. The zebrafish and human MTMR5 proteins are highly conserved, and deletion of the mtmr5 gene in zebrafish results in a phenotype similar to that of human CMT4B3 patients. The goal of my research project is to utilize the CMT4B3 zebrafish model to investigate the role of MTMR5 in nerve development and identify disease-related phenotypes that are suitable for large-scale drug screens. I hypothesize that the CMT4B3 zebrafish will facilitate the efficient discovery of novel therapies that can be translated to patients with CMT4B3. To investigate the role of MTMR5, I plan to study the central and peripheral nervous system of CMT4B3 zebrafish using various experimental techniques, such as electron microscopy and RNA sequencing. I also plan on tagging the zebrafish MTMR5 protein with a fluorescent label to investigate its tissue-specific patterning, sub-cellular localization, and protein-protein interactions in both healthy and affected neural development. Successful completion of this research project will lead to the identification of the first potential therapeutics for CMT4B3.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lindzon, Jordan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~